Streetbeat News

Earnings

ANIK

Anika Therapeutics (NASDAQ:ANIK) reported Q2 2024 adjusted EPS of $0.17, beating the $0.05 estimate by 240%. However, sales of $41.920M missed the $42.099M estimate by 0.43%. EPS decreased by 45.16% YoY, and sales decreased by 5.38% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:01 pm

AMN

AMN Healthcare has projected its Q3 2024 consolidated revenue to be between $660 million and $680 million, which is below the estimated $740.43 million.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:01 pm

WEST

Westrock Coffee (NASDAQ:WEST) reported Q2 2024 adjusted EPS of $(0.13), missing the $(0.08) estimate by 62.5%. Sales were $208.389M, missing the $214.467M estimate by 2.83% and down 7.26% from last year's $224.7M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:01 pm

DBX

Dropbox shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:01 pm

SKIN

Beauty Health (NASDAQ:SKIN) reported Q2 2024 GAAP EPS of $(0.10), missing the $(0.05) estimate. Sales were $90.6M, missing the $98.77M estimate. EPS decreased by 433.33% YoY, and sales decreased by 22.89% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:01 pm

AXDX

Accelerate Diagnostics (NASDAQ:AXDX) reported Q2 EPS of $(0.50), beating the estimate of $(0.55), and sales of $2.99M, missing the estimate of $3.01M. EPS improved significantly from $(2.97) last year, while sales saw a slight increase from $2.92M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:01 pm

PRA

ProAssurance (NYSE:PRA) reported Q2 2024 adjusted EPS of $0.23, beating the $0.10 estimate by 130%. Sales were $239.867M, slightly above the $239.598M estimate but down 3.23% from last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:01 pm

NRDY

Nerdy Inc. (NRDY) has revised its Q3 2024 revenue expectations to $35M-$38M, significantly below the estimated $49.36M. The company also cut its FY24 revenue outlook from $232M-$246M to $196M-$204M, below the estimated $237.57M. Adjusted EBITDA for Q3 is expected to be between negative $19M and negative $17M, and for the full year, between negative $21M and negative $19M. Despite these revisions, Nerdy expects a return to durable and profitable growth by the end of the year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:01 pm

EVH

Evolent Health shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 9:00 pm

DOCS

Doximity Inc (NYSE:DOCS) reported strong fiscal first-quarter results, with revenue and earnings surpassing analyst estimates. Revenue increased 17% year-over-year to $126.68 million, and adjusted earnings were 28 cents per share. Despite a decline in operating and free cash flow, the company expects continued growth in the second quarter and full year. Shares surged 23.07% after hours.

Portfolio Pulse from Adam Eckert

August 08, 2024 | 9:00 pm